Company intelligence / Profile preview

Gensei Global Industries

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Gensei Global Industries is an early-stage biotechnology company focused on developing next-generation metabolic therapies. The company specializes in the discovery and development of oral small molecule and peptide-based agonists targeting the GLP-1, GIP, and glucagon receptors. Their primary goal is to provide more accessible and effective treatments for chronic metabolic conditions, including obesity and type 2 diabetes, by moving beyond traditional injectable formats. Gensei leverages a proprietary drug discovery approach to optimize the potency and bioavailability of their lead candidates.

Therapeutic areas: EndocrinologyCardiovascularMetabolic Disorders
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Gensei Global Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gensei Global Industries.

Explore the full profile